AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023
31 Oktober 2023 - 9:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the Jefferies London Healthcare
Conference on Tuesday, November 14, 2023, at 4:30 p.m. Greenwich
Mean Time (8:30 a.m. Pacific Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc. AbCellera is breaking the
barriers of conventional antibody discovery to bring better
medicines to patients, sooner. AbCellera’s engine integrates expert
teams, technology, and facilities with the data science and
automation needed to propel antibody-based medicines from target to
clinic in nearly every therapeutic area with precision and speed.
AbCellera provides innovative biotechs and leading pharmaceutical
companies with a competitive advantage that empowers them to move
quickly, reduce cost, and tackle the toughest problems in drug
development. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231030819456/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024